Harmonization of Teleneuropsychological Assessment in Dementia
NCT07664865 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2026-06-24
Summary
The prevention and management of cognitive decline and dementia represent major healthcare challenges. Neuropsychological assessment is a key component of current diagnostic criteria for Mild Neurocognitive Disorder (mNCD) due to Alzheimer's disease (AD), supporting both diagnosis and patient follow-up. It enables the evaluation of cognitive domains, monitoring of disease progression, and assessment of treatment effects.
Digital tools offer standardized, objective, and scalable methods for cognitive evaluation. The growth of telemedicine and the widespread adoption of digital technologies, accelerated by the COVID-19 pandemic, have increased acceptance of remote healthcare solutions, including teleneuropsychology. Recent advances in mobile technology, together with lower costs and greater accessibility, have facilitated the large-scale implementation of digital cognitive assessments.
Tablet-based teleneuropsychological platforms are particularly advantageous for older adults, providing user-friendly interfaces and improving access to care for individuals with mobility limitations or those living in underserved areas. To promote harmonized neuropsychological assessment within the Italian Neuroscience and Neurorehabilitation Network (RIN), this multicenter study aims to establish normative data and clinically validate Tenèpsia®, an innovative tablet-based teleneuropsychological platform certified as a Class IIa Medical Device. The study will support its clinical and research use while evaluating its diagnostic performance in patients with neurocognitive disorders.
Conditions
Sponsors & Collaborators
-
University of Bari Aldo Moro
collaborator OTHER -
University of Campania Luigi Vanvitelli
collaborator OTHER -
Università degli Studi di Trento
collaborator OTHER -
IRCCS Istituto delle Scienze Neurologiche di Bologna
collaborator OTHER -
University of Palermo
collaborator OTHER -
Asst Degli Spedali Civili Di Brescia
collaborator OTHER -
Azienda Usl di Bologna
collaborator OTHER_GOV -
Istituto Auxologico Italiano
collaborator OTHER -
IRCCS National Neurological Institute "C. Mondino" Foundation
lead OTHER
Principal Investigators
-
Sara Bottiroli, PhD · Unit of Research in Cognitive Psycology
Eligibility
- Min Age
- 40 Years
- Max Age
- 89 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-12-01
- Primary Completion
- 2025-07-31
- Completion
- 2025-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Validation of the I-UDS Neuropsychological Battery
NCT05803122 ·Status: COMPLETED
-
Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related Disorders
NCT01316562 ·Status: UNKNOWN
-
Dementia and Mild Cognitive Impairment: Assessment of Cognitive Functioning, Functional Autonomy, and Neuropsychiatric Symptoms.
NCT07287410 ·Status: RECRUITING
-
Effects of Telerehabilitation on Brain Network Connectivity
NCT06278818 ·Status: RECRUITING ·Phase: NA
-
Adaptation of the Uniform Data Set for Telematic Administration
NCT05785910 ·Status: COMPLETED ·Phase: NA
-
Detecting Dementia Earlier
NCT03900936 ·Status: UNKNOWN
-
Italian Validation of the dNA Scale and Its Correlation With Neurocognitive Variables
NCT07533084 ·Status: NOT_YET_RECRUITING
-
Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease.
NCT07467460 ·Status: RECRUITING
-
Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment
NCT00684281 ·Status: COMPLETED ·Phase: NA
-
Validation of the Montreal Cognitive Assessment in Patients With Mild and Major Neurocognitive Disorder
NCT03581643 ·Status: COMPLETED
-
Computerized Cognitive Training in Neurodegenerative Diseases (NDD2019)
NCT04111640 ·Status: UNKNOWN ·Phase: NA
-
Neurological Soft Signs in Neurodegenerative Dementias
NCT06354933 ·Status: COMPLETED
-
Multimodal Assesment of Alzheimer Patients
NCT06448403 ·Status: RECRUITING
-
The Role of Humanoid Robot in Neuropsychological Assessment and Cognitive Training.
NCT05788133 ·Status: COMPLETED ·Phase: NA
-
Psychopathological Risk Factors Associated With Conversion From Mild Cognitive Impairment to Dementia
NCT01436552 ·Status: UNKNOWN
-
Neurocognitive Assessment Platform 4 Alzheimer
NCT07272811 ·Status: RECRUITING
-
Telemedicine Self-examination of Speech and Memory for Rapid Detection of Cognitive Impairments Using Machine Learning Methods
NCT07558785 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Mild Cognitive Impairment and Psychopathology
NCT07358962 ·Status: NOT_YET_RECRUITING
-
Identification of Proteostasis-related Biomarkers in Alzheimer´s Dementia
NCT02686554 ·Status: UNKNOWN
-
Cognition and NeuroImaging in neuroDegenerative Disorders (CogNID)
NCT03861884 ·Status: RECRUITING
-
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With Machine Learning
NCT05569083 ·Status: UNKNOWN
-
Non-expensive and Widely Available Tests as Diagnostic Tools in Dementia and Their Ability to Predict Disease Progression
NCT01642420 ·Status: UNKNOWN
-
DIagnostic Biomarkers and Symptoms in Patients With Alzheimer's Disease and Lewy bodY Dementia
NCT05768425 ·Status: ACTIVE_NOT_RECRUITING
-
Comparison Between Analog Neurocognitive Tests Conducted by a Trained Test Leader Versus Self-administered Digital Tests
NCT05253612 ·Status: COMPLETED ·Phase: NA
-
New Virtual Reality Technologies and Telemedicine for Cognitive Rehabilitation in Alzheimer's Disease
NCT05697354 ·Status: COMPLETED ·Phase: NA